After reading about the approval process for new drugs on the FDA website, my understanding is that a decision regarding Priority versus Standard Review is made within 45 days of submission. If so, a decision should have already been made?
By the way, Gleevac - also for the treatment of chronic myeloid leukemia - was granted approval within 4 months.
this stock is da bomb, page-32
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)